Does Social Media Impact Adolescent Mental Health?
Launched by GEORGETOWN UNIVERSITY · Sep 16, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how social media might affect the mental health of young people, specifically adolescents aged 10 to 14 years. Since 2011, there has been a noticeable decline in the mental well-being of teenagers in the United States, which seems to correlate with the rise of social media and smartphones. The researchers want to find out if social media is truly harmful to adolescents' mental health or if the concerns about it are exaggerated. To do this, they will conduct an experiment with young teens who are getting their first smartphones.
To participate, eligible adolescents need to be between 10 and 14 years old and have parents who are willing to allow them to join the study. The teens also need to be able to read and understand English to complete surveys. However, those with severe developmental issues or a history of serious mental health problems, including suicidal thoughts, cannot take part in the study. If selected to join, participants can expect to be involved in activities that help researchers gather information on how social media impacts their mental health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. is an adolescent who is between the ages of 10 and 14;
- • 2. is an adolescent whose parents have decided to buy them their first smartphone;
- • 3. is an adolescent both of whose parents/guardians consent for them to be in the study;
- • 4. is an adolescent who assents to be in the study; 5) is an adolescent who speaks and reads English sufficiently to complete surveys and provide informed consent.
- Exclusion Criteria:
- • 1. is an adolescent who has severe developmental problems (e.g., autism, severe language delay);
- • 2. is an adolescent who is currently or has ever been diagnosed with severe or moderately severe mental illness;
- • 3. is an adolescent who is currently or has ever experienced suicidal ideation.
About Georgetown University
Georgetown University is a prestigious academic institution renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, Georgetown University leverages its extensive resources and expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among multidisciplinary teams, emphasizing ethical practices and adherence to regulatory standards. With a focus on translating scientific discoveries into clinical applications, Georgetown University plays a vital role in enhancing patient care and contributing to the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Washington, District Of Columbia, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported